Wall Street Has a Mixed Opinion on Ambev S.A (ABEV), Here’s Why

Ambev S.A (NYSE:ABEV) is one of the Best Low Cost Stocks to Buy According to Analysts. Wall Street has a mixed opinion on Ambev S.A (NYSE:ABEV) after the company missed revenue estimates for its fiscal second quarter of 2025. The company delivered $3.59 billion in revenue, which grew around 2.65% year-over-year but fell short of expectations by $250.95 million. The EPS of $0.03 stayed in line with the consensus.

Management noted that its total organic volumes decreased by 4.5% year-over-year due to industry softness. This was mainly due to the colder temperatures, which negatively affected key consumption occasions, particularly in the South and Southeast regions, which account for nearly 60% of the industry demand.

Wall Street has had a mixed opinion on Ambev S.A (NYSE:ABEV) since its earnings release. On August 1, Evercore ISI reiterated a Buy rating on the stock with a price target of $4. However, more recently, on August 20, UBS reiterated a Hold rating on the stock, while reducing the price target from $2.5 to $2.2.

Ambev S.A (NYSE:ABEV) is a Brazil-based company that brews, distributes, and sells beer, soft drinks, and other beverages across the Americas.

While we acknowledge the potential of ABEV to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than ABEV and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.